San Carlos, CA30+ days ago
The company leverages Attobody, a novel biologics platform, to generate small format biparatopic binders that expand the addressable target universe across disease areas and can offer stronger efficacy, faster speed to response, and an improved safety profile than traditional approaches. Assist in authoring clinical-regulatory documents, including study protocols, investigator brochures, IND/CTAs, informed consents, clinical study reports, procedure manuals, statistical analysis plans, and briefing documents for health authorities.